Fortis Healthcare is showing signs of a bullish breakout with upside potential toward ₹770, supported by both strong technical indicators and an encouraging business outlook, according to SEBI-registered analyst Gaurav Narendra Puri.
Puri has set a one-month price target range of ₹735–₹770 with a stop-loss at ₹697, noting that the stock is emerging from a rectangle consolidation pattern on the daily chart.
At the time of writing, Fortis Healthcare shares were trading at ₹715.00, up 0.74% on the day
He cited a strong bounce from the 20-day exponential moving average (EMA) and rising volumes as indicators of renewed momentum, while the Relative Strength Index (RSI) at 62 signals ongoing bullish sentiment.
From a fundamental perspective, Puri highlighted Fortis’s improving book value over the past three years, a low price-to-intrinsic value ratio of 0.363, and a healthy return on equity of 12.48%.
The analyst’s technical and valuation-based optimism is further bolstered by Fortis’s strong FY26 guidance.
The hospital segment is expected to deliver 14%–15% revenue growth, aided by a 5–6% increase in ARPOBs (Average Revenue Per Occupied Bed), and margin expansion of 150–200 basis points.
Meanwhile, the diagnostics business is projected to deliver double-digit revenue growth, with core profit margins on net revenue forecasted at 23% and potential to reach 25% in the coming years.